The SARS-CoV-19 pandemic overwhelmed multiple healthcare systems across the world. Patients with underlying medical conditions such as obesity or diabetes were particularly vulnerable, had more severe symptoms, and were more frequently hospitalized. To date, there have been many studies on the severity of SARS-CoV-2 in patients with metabolic disorders, but data on the efficiency of vaccines against COVID-19 are still limited. This paper aims to provide a comprehensive overview of the effectiveness of COVID-19 vaccines in individuals with diabetes, insulin resistance, and obesity. A comparison is made between the immune response after vaccination in patients with and without metabolic comorbidities. Additionally, an attempt is made to highlight the mechanisms of immune stimulation affected by SARS-CoV-2 vaccines and how metabolic comorbidities modulate these mechanisms. The focus is on the most common COVID-19 vaccines, which include mRNA vaccines such as Pfizer-BioNTech and Moderna, as well as viral vector vaccines such as AstraZeneca and Johnson & Johnson. Furthermore, an effort is made to clarify how the functional differences between these vaccines may impact the response in individuals with metabolic disorders, drawing from available experimental data. This review summarizes the current knowledge regarding the post-vaccination response to COVID-19 in the context of metabolic comorbidities such as diabetes, insulin resistance, and obesity.

More from our Archive

• DOI: 10.3390/vaccines11071217 2023

  Artificial Intelligence and Public Health: Evaluating ChatGPT Responses to Vaccination Myths and Misconceptions

  Giovanna Deiana, Marco Dettori, Antonella Arghittu, Antonio Azara, Giovanni Gabutti, Paolo Castiglia

• DOI: 10.1111/apt.17622 2023

  Review article: Translating STRIDE‐II into clinical reality – Opportunities and challenges

  Axel Dignass, Stefan Rath, Thomas Kleindienst, Andreas Stallmach

• DOI: 10.1111/cns.14341 2023

  Evaluation of <scp>α‐synuclein</scp> in <scp>CNS</scp>‐originating extracellular vesicles for Parkinsonian disorders: A systematic review and meta‐analysis

  Hash Brown Taha, Shomik S. Ati

• DOI: 10.3390/jnt4030012 2023

  Emerging Trends in the Application of Green Synthesized Biocompatible ZnO Nanoparticles for Translational Paradigm in Cancer Therapy

  Shaikh Sheeran Naser, Basab Ghosh, Faizan Zarreen Simnani, Dibyangshee Singh, Anmol Choudhury, Aditya Nandi, Adrija Sinha, Ealisha Jha, Pritam Kumar Panda, Mrutyunjay Suar, Suresh K. Verma

• DOI: 10.1111/apt.17637 2023

  Clinical utility of liver fat quantification for determining cardiovascular disease risk among patients with type 2 diabetes

  Selena Z. Kuo, Sandra Cepin, Jaclyn Bergstrom, Harris Siddiqi, Jinho Jung, Scarlett Lopez, Daniel Q. Huang, Pam Taub, Maral Amangurbanova, Rohit Loomba

• DOI: 10.1111/cns.14333 2023

  Ultrasound reduces inflammation by modulating <scp>M1</scp>/<scp>M2</scp> polarization of microglia through <scp>STAT1</scp>/<scp>STAT6</scp>/<scp>PPARγ</scp> signaling pathways

  Chin‐Hung Hsu, Yi‐Ju Pan, Yin‐Ting Zheng, Raymond Y. Lo, Feng‐Yi Yang

• DOI: 10.1111/apt.17631 2023

  Effects of social determinants of health on mortality and incident liver‐related events and cardiovascular disease in steatotic liver disease

  Vincent L. Chen, Michael W. Song, Deepika Suresh, Sharad I. Wadhwani, Ponni Perumalswami

• DOI: 10.3390/vaccines11071181 2023

  The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice

  Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, Snezhina Lazova, Lyubomir Chervenkov, Monika Peshevska-Sekulovska, Metodija Sekulovski, Milena Gulinac, Georgi V. Vasilev, Luchesar Tomov, Tsvetelina Velikova

• DOI: 10.3390/vaccines11071177 2023

  COVID-19 Booster Dose Coverage and Hesitancy among Older Adults in an Urban Slum and Resettlement Colony in Delhi, India

  Nandini Sharma, Saurav Basu, Heena Lalwani, Shivani Rao, Mansi Malik, Sandeep Garg, Rahul Shrivastava, Mongjam Meghachandra Singh

• DOI: 10.1093/jac/dkad208 2023

  Effectiveness of sitafloxacin monotherapy for quinolone-resistant rectal and urogenital <i>Mycoplasma genitalium</i> infections: a prospective cohort study

  Naokatsu Ando, Daisuke Mizushima, Misao Takano, Morika Mitobe, Kai Kobayashi, Hiroaki Kubota, Hirofumi Miyake, Jun Suzuki, Kenji Sadamasu, Takahiro Aoki, Koji Watanabe, Haruka Uemura, Yasuaki Yanagawa, Hiroyuki Gatanaga, Shinichi Oka